4.39
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EKSO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$4.38
Offen:
$4.27
24-Stunden-Volumen:
2,885
Relative Volume:
0.06
Marktkapitalisierung:
$11.54M
Einnahmen:
$18.28M
Nettoeinkommen (Verlust:
$-15.20M
KGV:
-3.9909
EPS:
-1.1
Netto-Cashflow:
$-12.21M
1W Leistung:
+8.93%
1M Leistung:
-13.75%
6M Leistung:
+4.60%
1J Leistung:
-56.46%
Ekso Bionics Holdings Inc Stock (EKSO) Company Profile
Firmenname
Ekso Bionics Holdings Inc
Sektor
Telefon
510-984-1761
Adresse
101 GLACIER POINT, SAN RAFAEL
Vergleichen Sie EKSO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
EKSO
Ekso Bionics Holdings Inc
|
4.3994 | 11.49M | 18.28M | -15.20M | -12.21M | -1.10 |
|
ISRG
Intuitive Surgical Inc
|
577.04 | 205.21B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.59 | 56.03B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
79.80 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
256.43 | 37.34B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
277.69 | 20.20B | 2.96B | 487.70M | 344.00M | 6.6758 |
Ekso Bionics Holdings Inc Stock (EKSO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2016-10-14 | Eingeleitet | SunTrust | Buy |
Ekso Bionics Holdings Inc Aktie (EKSO) Neueste Nachrichten
Physical AI Market Size to Expand at 31.26% CAGR, to Capture USD 61.19 Billion 2034 - GlobeNewswire Inc.
Human Augmentation Market Covering Prime Factors - openPR.com
Ekso Bionics (EKSO) Upgraded to Buy: Here's Why - sharewise.com
How forex fluctuations impact Ekso Bionics Holdings Inc. (23E0) stock2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
Why Ekso Bionics Holdings Inc. (23E0) stock could rally stronglyPortfolio Value Summary & Expert Verified Movement Alerts - newser.com
What is the fair value estimate for Ekso Bionics Holdings Inc. (23E0) stock in 2025Market Sentiment Summary & Smart Investment Allocation Tips - newser.com
Will Ekso Bionics Holdings Inc. (23E0) stock benefit from sector leadershipJuly 2025 Fed Impact & Free Verified High Yield Trade Plans - newser.com
Ekso Bionics Q2 2025 slides: Personal exoskeleton focus amid 58% revenue drop - Investing.com Nigeria
Earnings call transcript: Ekso Bionics Q2 2025 sees revenue drop, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: Ekso Bionics Q2 2025 sees revenue drop, stock rises - Investing.com Australia
Is Ekso Bionics Holdings Inc. stock vulnerable to regulatory risks - newser.com
Is Ekso Bionics Holdings Inc. (23E0) stock a fit for income portfoliosSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com
Will Ekso Bionics Holdings Inc. (23E0) stock profit from fiscal stimulusIPO Watch & Low Drawdown Investment Strategies - newser.com
H.C. Wainwright raises Ekso Bionics stock price target to $6 on sales recovery - Investing.com Australia
What recovery options are there for Ekso Bionics Holdings Inc.July 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com
Can Ekso Bionics Holdings Inc. stock continue upward trendWeekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com
How Ekso Bionics Holdings Inc. (23E0) stock reacts to Fed tightening2025 Bull vs Bear & Real-Time Volume Analysis - newser.com
Why global investors buy Ekso Bionics Holdings Inc. (23E0) stockJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Finanzdaten der Ekso Bionics Holdings Inc-Aktie (EKSO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ekso Bionics Holdings Inc-Aktie (EKSO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Jones Jason C | Chief Operating Officer |
Nov 10 '25 |
Sale |
4.80 |
9,723 |
46,670 |
27,211 |
| Davis Scott G. | CEO |
Nov 10 '25 |
Sale |
4.80 |
23,315 |
111,912 |
78,777 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):